NCT03404362View on ClinicalTrials.gov

MRgFUS Versus EBRT in Patients With Metastatic Non-spinal Bone Disease

NACompletedINTERVENTIONAL
Enrollment

198

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

May 31, 2019

Study Completion Date

September 30, 2020

Conditions
Secondary Bone CancerBone Metastases
Interventions
PROCEDURE

Bone Metastases Pain treatment

Comparative treatments to test if MRgFUS is an effective non-invasive and safe treatment for the palliation of metastatic bone tumors with a low incidence of co-morbidity as compared to EBRT (gold-standard)

Trial Locations (2)

00100

Alessandro Napoli, Rome

Unknown

Sapienza University of Rome, Policlinico Umberto I Hospital, Rome

All Listed Sponsors
lead

University of Roma La Sapienza

OTHER

NCT03404362 - MRgFUS Versus EBRT in Patients With Metastatic Non-spinal Bone Disease | Biotech Hunter | Biotech Hunter